Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004817

Chief Commercial Officer, MRD sold 26,023 shares at $6.98 ($181,641)

  • Chief Commercial Officer, MRD acquired 119,971 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BOBULSKY SUSAN · Chief Commercial Officer, MRD

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-04 Grant or award : show line 1 in the form +119,971 373,261 D
2025-03-05 Sale : show line 2 in the form −26,023 $6.98 $181,641 347,238 D
Open-market sales · 26,023 sh · avg $6.98 · $181,641

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-04 Grant or award : show line 3 in the form Stock Option (right to buy) +180,029 180,029 D
Loading xslF345X05/form4.xml…